• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An overview of naturally occurring histone deacetylase inhibitors.天然存在的组蛋白去乙酰化酶抑制剂概述。
Curr Top Med Chem. 2015;14(24):2759-82. doi: 10.2174/1568026615666141208105614.
2
The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors.开发选择性组蛋白去乙酰化酶 3 抑制剂的过程和策略。
Molecules. 2018 Mar 2;23(3):551. doi: 10.3390/molecules23030551.
3
From natural products to HDAC inhibitors: An overview of drug discovery and design strategy.从天然产物到组蛋白去乙酰化酶抑制剂:药物发现和设计策略概述。
Bioorg Med Chem. 2021 Dec 15;52:116510. doi: 10.1016/j.bmc.2021.116510. Epub 2021 Nov 10.
4
Natural products as zinc-dependent histone deacetylase inhibitors.作为锌依赖性组蛋白脱乙酰酶抑制剂的天然产物。
ChemMedChem. 2015 Mar;10(3):441-50. doi: 10.1002/cmdc.201402460. Epub 2015 Jan 7.
5
Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.组蛋白去乙酰化酶的天然产物抑制剂作为新型抗癌药物
Curr Protein Pept Sci. 2018;19(3):333-340. doi: 10.2174/1389203718666170106101133.
6
Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.天然组蛋白去乙酰化酶(HDAC)抑制剂作为抗癌药物的发现和发展进展。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):675-702. doi: 10.1007/s00210-023-02674-4. Epub 2023 Aug 24.
7
Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.聚焦乙酰化:组蛋白去乙酰化酶抑制剂在癌症治疗及其他方面的作用
Expert Opin Investig Drugs. 2007 May;16(5):569-71. doi: 10.1517/13543784.16.5.569.
8
HDACs and HDAC Inhibitors in Cancer Development and Therapy.组蛋白去乙酰化酶及组蛋白去乙酰化酶抑制剂在癌症发生与治疗中的作用
Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):a026831. doi: 10.1101/cshperspect.a026831.
9
Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?组蛋白去乙酰化酶抑制剂:神经紊乱治疗的关键?
J Neuropathol Exp Neurol. 2018 Oct 1;77(10):855-870. doi: 10.1093/jnen/nly073.
10
Role of Natural Products in Modulating Histone Deacetylases in Cancer.天然产物在调节癌症中组蛋白去乙酰化酶中的作用。
Molecules. 2019 Mar 16;24(6):1047. doi: 10.3390/molecules24061047.

引用本文的文献

1
Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma.硫氧还蛋白相互作用蛋白激活的细胞内钾缺失介导新型组蛋白乙酰化抑制剂 HL23(汉防己甲素衍生物)在人肝癌中的抗肿瘤作用。
J Adv Res. 2023 Sep;51:181-196. doi: 10.1016/j.jare.2022.10.017. Epub 2022 Nov 9.
2
Top-"Double-Down" Mass Spectrometry of Histone H4 Proteoforms: Tandem Ultraviolet-Photon and Mobility/Mass-Selected Electron Capture Dissociations.组蛋白 H4 蛋白变体的顶部“双下降”质谱法:串联紫外光子和迁移率/质量选择电子俘获解离。
Anal Chem. 2022 Nov 8;94(44):15377-15385. doi: 10.1021/acs.analchem.2c03147. Epub 2022 Oct 25.
3
The Multifaceted Neurotoxicity of Astrocytes in Ageing and Age-Related Neurodegenerative Diseases: A Translational Perspective.衰老及年龄相关神经退行性疾病中星形胶质细胞的多方面神经毒性:转化医学视角
Front Physiol. 2022 Mar 17;13:814889. doi: 10.3389/fphys.2022.814889. eCollection 2022.
4
Untargeted LC-MS/MS Metabolomics Study on the MCF-7 Cell Line in the Presence of Valproic Acid.未靶向 LC-MS/MS 代谢组学研究丙戊酸存在下 MCF-7 细胞系。
Int J Mol Sci. 2022 Feb 28;23(5):2645. doi: 10.3390/ijms23052645.
5
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention.靶向组蛋白去乙酰化酶:癌症治疗与化学预防的机遇
Pharmaceutics. 2022 Jan 16;14(1):209. doi: 10.3390/pharmaceutics14010209.
6
Cyclic Tetrapeptide HDAC Inhibitors with Improved Selectivity and Killing Profile.具有改善的选择性和杀伤谱的环状四肽 HDAC 抑制剂。
ACS Infect Dis. 2021 Oct 8;7(10):2889-2903. doi: 10.1021/acsinfecdis.1c00341. Epub 2021 Sep 7.
7
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites.锚定延伸:一种设计靶向酶活性位点的环状肽的结构导向方法。
Nat Commun. 2021 Jun 7;12(1):3384. doi: 10.1038/s41467-021-23609-8.
8
Structure-activity relationship of ipglycermide binding to phosphoglycerate mutases.异丙甘油酰胺与磷酸甘油酸变位酶结合的构效关系。
J Biol Chem. 2021 Jan-Jun;296:100628. doi: 10.1016/j.jbc.2021.100628. Epub 2021 Apr 1.
9
Histone Deacetylase Inhibitors from Marine Invertebrates.来自海洋无脊椎动物的组蛋白去乙酰化酶抑制剂
Biology (Basel). 2020 Nov 28;9(12):429. doi: 10.3390/biology9120429.
10
Chromatin-modifying drugs and metabolites in cell fate control.染色质修饰药物及其代谢产物在细胞命运调控中的作用。
Cell Prolif. 2020 Nov;53(11):e12898. doi: 10.1111/cpr.12898. Epub 2020 Sep 26.

本文引用的文献

1
Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties.通过改变前药性质对基于拉加唑的组蛋白去乙酰化酶抑制剂活性谱的调控
ACS Med Chem Lett. 2014 Jul 7;5(8):905-10. doi: 10.1021/ml500170r. eCollection 2014 Aug 14.
2
Evaluation of class I HDAC isoform selectivity of largazole analogues.I类组蛋白去乙酰化酶(HDAC)亚型对拉戈唑类似物的选择性评估
Bioorg Med Chem Lett. 2014 Aug 15;24(16):3728-31. doi: 10.1016/j.bmcl.2014.07.006. Epub 2014 Jul 9.
3
Biological evaluation of new largazole analogues: alteration of macrocyclic scaffold with click chemistry.新型拉戈唑类似物的生物学评价:通过点击化学改变大环骨架
ACS Med Chem Lett. 2012 Dec 5;4(1):132-6. doi: 10.1021/ml300371t. eCollection 2013 Jan 10.
4
HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis.组蛋白去乙酰化酶6(HDAC6)在胆管囊肿细胞中过表达,抑制该酶可减少囊肿形成。
Am J Pathol. 2014 Mar;184(3):600-8. doi: 10.1016/j.ajpath.2013.11.027. Epub 2014 Jan 13.
5
HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.抑制组蛋白去乙酰化酶 4:一种针对细胞质亨廷顿蛋白的新型治疗策略,可改善神经退行性变。
PLoS Biol. 2013 Nov;11(11):e1001717. doi: 10.1371/journal.pbio.1001717. Epub 2013 Nov 26.
6
Structure elucidation and antimalarial activity of apicidin F: an apicidin-like compound produced by Fusarium fujikuroi.结构阐明和抗疟活性的阿皮定 F:一种由藤仓镰刀菌产生的类似阿皮定的化合物。
J Nat Prod. 2013 Nov 22;76(11):2136-40. doi: 10.1021/np4006053. Epub 2013 Nov 6.
7
Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp.Santacruzamate A,一种来自巴拿马海洋蓝细菌 cf. Symploca sp. 的强效和选择性组蛋白去乙酰化酶抑制剂。
J Nat Prod. 2013 Nov 22;76(11):2026-33. doi: 10.1021/np400198r. Epub 2013 Oct 28.
8
Discovery and activity profiling of thailandepsins A through F, potent histone deacetylase inhibitors, from E264.从E264中发现并分析泰国蛋白酶A至F(强效组蛋白去乙酰化酶抑制剂)的活性。
Medchemcomm. 2012 Aug 1;3(8):976-981. doi: 10.1039/C2MD20024D.
9
Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E.阿祖酰胺 A-E 以及 β²-epi-Azumamide E 和 β³-epi-Azumamide E 的全合成及全面组蛋白去乙酰化酶抑制谱分析。
J Med Chem. 2013 Aug 22;56(16):6512-20. doi: 10.1021/jm4008449. Epub 2013 Aug 5.
10
Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophages.组蛋白去乙酰化酶 7 促进巨噬细胞中 Toll 样受体 4 依赖性促炎基因表达。
J Biol Chem. 2013 Aug 30;288(35):25362-25374. doi: 10.1074/jbc.M113.496281. Epub 2013 Jul 12.

天然存在的组蛋白去乙酰化酶抑制剂概述。

An overview of naturally occurring histone deacetylase inhibitors.

作者信息

Kim Bumki, Hong Jiyong

机构信息

Duke University, Department of Chemistry, 124 Science Drive, Box 90346, Durham, NC 27708, USA.

出版信息

Curr Top Med Chem. 2015;14(24):2759-82. doi: 10.2174/1568026615666141208105614.

DOI:10.2174/1568026615666141208105614
PMID:25487010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6805157/
Abstract

Histone deacetylases (HDACs) have recently emerged as key elements in epigenetic control of gene expression. Due to the implication of HDACs in a variety of diseases ranging from cancer to neurodegenerative disorder, HDAC inhibitors have received increased attention in recent years. Over the last few decades, a myriad of HDAC inhibitors containing a wide variety of structural features have been identified from natural sources. Here, we review the discovery, synthesis, biological properties, and modes of action of these naturally occurring HDAC inhibitors and consider their implications for future research.

摘要

组蛋白脱乙酰酶(HDACs)最近已成为基因表达表观遗传控制中的关键要素。由于HDACs涉及从癌症到神经退行性疾病等多种疾病,近年来HDAC抑制剂受到了越来越多的关注。在过去几十年中,已从天然来源鉴定出无数具有各种结构特征的HDAC抑制剂。在此,我们综述这些天然存在的HDAC抑制剂的发现、合成、生物学特性和作用模式,并考虑它们对未来研究的意义。